Page 76 - Read Online

Page 10 of 11 Fontan et al. Mini-invasive Surg 2020;4:29 I http://dx.doi.org/10.20517/2574-1225.2020.09

obesity-associated pseudotumor cerebri. Neurology 1997;49:507-11.
17. de Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease:
relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol 2008;103:1349-54.
18. Herbella FA, Sweet MP, Tesesco P, Nipomnick I, Patti MG. Gastroesophageal reflux disease and obesity. Pathophysiology and
implications for treatment. J Gastrointest Surg 2007;11:286-90.
19. Chang P, Friedenberg F. Obesity & GERD. Gastroenterol Clin North Am 2014;43:161-73.
20. Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Eklund S. Esophageal stricture: incidence, treatment patterns, and
recurrence rate. Am J Gastroenterol 2006;101:2685-92.
21. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Eng J Med 1985;313:857-9.
22. Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, Lind T, et al. Erosive esophagitis is a risk factor for Barrett’s esophagus: a
community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946-52.
23. Akiyama T, Yoneda M, Inamori M, Iida H, Endo H, et al. Visceral obesity and the risk of Barrett’s esophagus in Japanese patients with
non-alcoholic fatty liver disease. BMC Gastroenterol 2009;9:56.
24. Wood RK, Yang YX. Barrett’s esophagus in 2008: an update. Keio J Med 2008;57:132-8.
25. Corley DA, Kubo A, Levin TR, Block G, Habel L, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus.
Gastroenterology 2007;133:34-41.
26. Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet 2009;373:850-61.
27. Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, et al. Efficacy of Nissen fundoplication versus medical therapy in the regression of
low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 2006;243:58-63.
28. Parrilla P, Martínez de Haro LF, Ortiz A, Munitiz V, Molina J, et al. Long-term results of a randomized prospective study comparing
medical and surgical treatment of Barrett’s esophagus. Ann Surg 2003;237:291-8.
29. Chang EY, Morris CD, Seltman AK, O’Rourke RW, Chan BK, et al. The effect of antireflux surgery on esophageal carcinogenesis in
patients with barrett esophagus: a systematic review. Ann Surg 2007;246:11-21.
30. Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, et al. Long-term omeprazole treatment in resistant gastro-esophageal reflux
disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000;118:661-9.
31. Marshall RE, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-
oesophageal bile reflux in Barrett’s oesophagus. Gut 1998;43:603-6.
32. Waring JP. Postfundoplication complications. Prevention and management. Gastroenterol Clin North Am 1999;28:1007-19.
33. Spechler SJ. Does Barrett’s esophagus regress after surgery (or proton pump inhibitors)? Dig Dis 2014;32:156-63.
34. Adil MT, Al-Taan O, Rashid F, Munasinghe A, Jain V, et al. A systematic review and meta-analysis of the effect of roux-en-Y gastric
bypass on Barrett’s esophagus. Obes Surg 2019;29:3712-21.
35. Braghetto I, Lanzarini E, Korn O, Valladares H, Molina JC, et al. Manometric changes of the lower esophageal sphincter after sleeve
gastrectomy in obese patients. Obes Surg 2010;20:357-62.
36. Genco A, Soricelli E, Casella G, Maselli R, Castagneto-Gissey L, et al. Gastroesophageal reflux disease and Barrett’s esophagus after
laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis 2017;13:568-74.
37. Soricelli E, Casella G, Baglio G, Maselli R, Ernesti I, et al. Lack of correlation between gastroesophageal reflux disease symptoms and
esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis 2018;14:751-6.
38. Sebastianelli L, Benois M, Vanbiervliet G, Bailly L, Robert M, et al. Systematic endoscopy 5 years after sleeve gastrectomy results in a
high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg 2019;29:1462-9.
39. Felsenreich DM, Kefurt R, Schermann M, Beckerhinn P, Kristo I, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic
sleeve gastrectomy: long-term follow-up. Obes Surg 2017;27:3092-101.
40. Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, et al.; Clinical Guidelines Committee of the American College of
Physicians. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the
American College of Physicians. Ann Intern Med 2012;157:808-16.
41. Levine MS, Rubesin SE. History and evolution of the barium swallow for evaluation of the pharynx and esophagus. Dysphagia
2017;32:55-72.
42. Howard PJ, Maher L, Pryde A, Cameron EW, Heading RC. Five year prospective study of the incidence, clinical features, and diagnosis
of achalasia in Edinburgh. Gut 1992;33:1011-5.
43. Grimes OF, Stephens HB, Margulis AR. Achalasia of the esophagus. Am J Surg 1970;120:198-202.
44. Arber N, Grossman A, Lurie B, Hoffman M, Rubinstein A, et al. Epidemiology of achalasia in central Israel. Rarity of esophageal cancer.
Dig Dis Sci 1993;38:1920-5.
45. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, et al. Guidelines for surgical treatment of gastroesophageal reflux
disease. Surg Endosc 2010;24:2647-69.
46. Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA. Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final
results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech 2015;25:787-92.
47. Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, et al. Long-term outcomes of patients receiving a magnetic sphincter
augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 2016;14:671-7.
48. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001;15:986-9.
49. Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of
long-term outcomes. Surg Endosc 2007;21:1978-84.